Engineers Gate Manager’s Taysha Gene Therapies TSHA Stock Holding History

Engineers Gate Manager’s Portfolio TSHA Stock Details TSHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$709K	Buy	+104,132	New	+$616K	0.01%	1281
2025 Q4	–	Sell	-53,483	Closed	-$175K	–	2556
2025 Q3	$175K	Sell	53,483 -11,134	-17%	-$31.5K	﹤0.01%	1933
2025 Q2	$149K	Buy	+64,617	New	+$140K	﹤0.01%	1942
2025 Q1	–	Sell	-35,808	Closed	-$61.9K	–	2591
2024 Q4	$61.9K	Buy	+35,808	New	+$74.3K	﹤0.01%	2054
2024 Q2	–	Sell	-110,992	Closed	-$319K	–	2244
2024 Q1	$319K	Buy	110,992 +89,296	+412%	+$186K	0.01%	1431
2023 Q4	$38.4K	Buy	+21,696	New	+$43.3K	﹤0.01%	1868
2023 Q3	–	Sell	-13,650	Closed	-$9.02K	–	2091
2023 Q2	$9.02K	Hold	13,650	–	–	﹤0.01%	1689
2023 Q1	$10.9K	Buy	+13,650	New	+$17.6K	﹤0.01%	1598

Other funds holding TSHA

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Engineers Gate Manager's TSHA Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 104,132 shares worth $709K. The stake represents 0.01% of the portfolio and ranks #1281 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in TSHA as recently as Q3 2025.

Engineers Gate Manager first reported a position in TSHA in Q1 2023 and has held it in 8 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

Engineers Gate Manager held 104,132 shares of Taysha Gene Therapies worth $709K as of Q2 2026.
Taysha Gene Therapies was a new Engineers Gate Manager position in Q2 2026.
Taysha Gene Therapies made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1281 holding.
Engineers Gate Manager first reported a position in Taysha Gene Therapies in Q1 2023 and has held it in 8 quarters since.
209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.